Literature DB >> 21514453

The beneficial effects of statin therapy may not apply to all forms of crescentic glomerulonephritis.

Bahjat Al-Ani, Hamad Al Nuaimi, Caroline Savage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21514453      PMCID： PMC3081163          DOI： 10.1016/j.ajpath.2010.12.058

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  18 in total

Review 1.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 2.  Statins for improving renal outcomes: a meta-analysis.

Authors:  Sabrina Sandhu; Natasha Wiebe; Linda F Fried; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 10.121

3.  Statin therapy does not seem to benefit giant cell arteritis.

Authors:  Javier Narváez; Berta Bernad; Joan M Nolla; José Valverde
Journal:  Semin Arthritis Rheum       Date:  2007-01-03       Impact factor: 5.532

Review 4.  Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.

Authors:  B Noël
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-01       Impact factor: 6.166

Review 5.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

Review 6.  Statins and renal diseases: from primary prevention to renal replacement therapy.

Authors:  Giuseppe D'Amico
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

7.  Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo.

Authors:  Mark A Little; C Lucy Smyth; Rashmi Yadav; Lyn Ambrose; H Terence Cook; Sussan Nourshargh; Charles D Pusey
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

Review 8.  HMG-CoA reductase inhibitors and the kidney.

Authors:  V M Campese; J Park
Journal:  Kidney Int       Date:  2007-05-09       Impact factor: 10.612

Review 9.  Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response.

Authors:  Xin Zhang; Silva Markovic-Plese
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

Authors:  Shannon E Dunn; Sawsan Youssef; Matthew J Goldstein; Thomas Prod'homme; Martin S Weber; Scott S Zamvil; Lawrence Steinman
Journal:  J Exp Med       Date:  2006-02-13       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.